题名

乳癌的中西醫觀點暨自然療法初探

并列篇名

Views of Traditional Chinese and Western Medicine and Preliminary Exploration of Naturopathy on Breast Cancer

DOI

10.7102/JTCIM.202012_18(2).0003

作者

呂琇蓉(Lu, Hsiu-Jung)；趙恆翊(Chao, Heng-Yi)；王育才(Wang, Yu-Tsai)

关键词

乳癌 ； 中醫 ； 放射治療 ； 化學治療 ； 荷爾蒙治療 ； breast cancer ； Traditional Chinese medicine ； radiotherapy ； chemotherapy ； hormone therapy

期刊名称

中醫內科醫學雜誌

卷期/出版年月

18卷2期（2020 / 12 / 01）

页次

35 - 47

内容语文

繁體中文
中文摘要

本乳癌不易早期自我發現。乳房致癌的危險因子包括不能改變的因子和可以改變的因子，是複雜的遺傳與環境或是基因與成熟的交互作用。乳癌的西醫治療方法包括手術切除、和放射線治療、化學治療、抗荷爾蒙治療及標靶治療，每種治療方式各有其副作用。絕大多數的台灣罹患乳癌婦女會接受西醫的手術治療，綜合治療是乳癌治療的主要發展方向。中西醫結合治療乳癌漸漸成為目前臨床治療的發展方向。乳癌患者求診中醫，並非完全只是為了治療乳癌或是西醫治療乳癌的副作用。中醫治療以及其他的補充、替代的或整合醫療作為西醫輔助療法是很普遍的，對於西醫治療乳癌患者之副作用的改善與生活品質之提昇確實有其療效；但是，這些補充、替代的或整合醫療亟待建立臨床指引。
英文摘要

Breast cancer is not easy to self-detect early. The risk factors for breast cancer include factors that cannot be changed and factors that can be changed. It is a complex interaction between heredity and environment or gene and maturity. Western medicine treatment methods for breast cancer include surgical resection, radiation therapy, chemotherapy, anti-hormonal therapy, and targeted therapy, each of which has its own side effects. The vast majority of women suffering from breast cancer in Taiwan will receive surgical treatment by Western medicine. Comprehensive treatment is the main development direction of breast cancer treatment. The treatment of breast cancer with integrated traditional Chinese and Western medicine has gradually become the current development direction of clinical treatment. The treatment of breast cancer patients with Chinese medicine is not solely for the treatment of breast cancer or the side effects of Western medicine treatment of breast cancer. Traditional Chinese medicine treatments and other complementary, alternative or integrated medical treatments are very common as adjuvant western medicines. They do have curative effects in improving the side effects and quality of life of breast cancer patients treated by western medicine; however, these complementary, alternative or integrated medical treatments are urgent to establish clinical guidelines.
主题分类 醫藥衛生 > 中醫藥學
参考文献
  1. 王育才,柯馨婷,陳正傑,呂琇蓉,賴英秀(2020)。乳癌化學治療引起味覺異常之病例報告。中醫婦科醫學雜誌，25，30-43。
    連結：
  2. 陳婉伶,蔡嘉一,黃怡嘉(2015)。比較中醫期刊文獻與台灣健保資料庫乳癌研究之用藥差異。中西整合醫學雜誌，17(3)，17-24。
    連結：
  3. 賴榮年,吳建東,王榮德(2013)。台灣乳癌婦女1998-2008 年間的中藥使用率及模式分析。中醫藥雜誌，24(1)，13-23。
    連結：
  4. 自由時報：肺癌蟬聯癌症死因之首，乳癌最折壽，2018 年6 月15 日，取自 https://news.ltn.com.tw/news/life/breakingnews/2459565。
  5. Balkwill, F,Mantovani, A(2001).Inflammation and cancer: back to Virchow?.Lancet,357(9255),539-545.
  6. Bower, JE,Ganz, P,Desmond, KA,Rowland, JH,Meyerowitz,Belin, TR(2000).Fatigue in breast cancer survivors: Occurrence, correlates and impact on quality of life.J Clin Oncol,18,743-753.
  7. Burgess, C,Cornelius, V,Love, S,Graham, J,Richards, M,Ramirez, A(2005).Depression and anxiety in women with early breast cancer: Five year observational cohort study.BMJ,330(7493),702-705.
  8. Chandwani, KD,Perkins, G,Nagendra, HR(2014).Randomized, Controlled Trial of Yoga in Women With Breast Cancer Undergoing Radiotherapy.J Clin Oncol,1058-1065.
  9. Chen, WY(2020).Chen WY Factors that modify breast cancer risk in women UpToDate Literature review last updated: Mar 05, 2020..
  10. DiSipio, T,Rye, S,Newman, B,Hayes, S(2013).Incidence of unilateral arm lymphedema after breast cancer: a systematic review and meta-analysis.Lancet Onc,14(6),500-515.
  11. Fallowfield, L,Jenkins, V(2014).Psychosocial/survivorship issues in breast cancer: are we doing better?.J Natl Cancer Inst,107(1),335.
  12. Fellowes, D,Fallowfield, LJ,Saunders, CM,Houghton, J(2001).Tolerability of hormone therapies for breast cancer: how informative are documented symptom profiles in medical notes for ‘welltolerated’ treatments?.Breast Cancer Res Treat,66(1),73-81.
  13. Glaser, AW,Fraser, LK,Corner, J(2013).Patient-reported outcomes of cancer survivors in England 15 years after diagnosis: a cross-sectional survey.BMJ Open,3,e002317.
  14. Goldman, Lee,Andrew, I. Schafer(2015).Goldman-Cecil Medicine.USA:Elsevier Saunders.
  15. Gradishar, WJ,Anderson, BO,Balassanian, R,Blair, SL,Burstein, HJ,Cyr, A,Elias, AD,Farrar, WB,Forero, A,Giordano, SH,Goetz, M,Goldstein, LJ,Hudis, CA,Isakoff, SJ,Marcom, PK,Mayer, IA,McCormick, B,Moran, M,Patel, SA,Pierce, LJ,Reed, EC,Salerno, KE,Schwartzberg, LS,Smith, KL,Smith, ML,Soliman, H,Somlo, G,Telli, M,Ward, JH,Shead, DA,Kumar, R(2015).Breast Cancer Version 2.2015.J Natl Compr Canc Netw,13(4),448-475.
  16. Greenlee, H,Balneaves, LG,Carlson, LE(2015).Clinical practice guidelines on the use of integrative therapies as supportive care in patients treated for breast cancer.J Natl Cancer Inst Monogr,2015(51),98.
  17. Hermelink, K,Untch, M,Lux, MP(2007).Cognitive function during neoadjuvant chemotherapy for breast cancer: Results of a prospective, multicenter, longitudinal study.Cancer,109(9),1905-1913.
  18. Horneber, M,Bueschel, G,Dennert, G,Less, D,Ritter, E,Zwahlen, M(2012).How many cancer patients use complementary and alternative medicine: a systematic review and metaanalysis.Integr Cancer Ther,11(3),187-203.
  19. International Agency for Research On Cancer. Press Release Dec 12, 2013. http://www.iarc.fr/en/media-centre/pr/2013/pdfs/pr223_E.pdf
  20. Lemann, J, Jr,Litzow, JR,Lennon, EJ(1966).The effects of chronic acid loads in normal man: further evidence for the participation of bone mineral in the defense against chronic metabolic acidosis.J Clin Invest,45(10),1608-1614.
  21. Lengacher, CA,Kip, KE,Post-White, J,Fitzgerald, S,Newton, C,Barta, M,Jacobsen, PB,Shelton, MM,Moscoso, M,Johnson-Mallard, V,Harris, E,Loftus, L,Cox, C,Le, N,Goodman, M,Djeu, J,Widen, RH,Bercu, BB,Klein, TW(2013).Lymphocyte recovery after breast cancer treatment and 32. mindfulness-based stress reduction (MBSR) therapy.Biol Res Nurs,15(1),37-47.
  22. Nurgali, K,Jagoe, RT,Abalo, R(2018).Editorial: Adverse Effects of Cancer Chemotherapy: Anything New to Improve Tolerance and Reduce Sequelae?.Front Pharmacol,9,245.
  23. O’Connor, AM,Bennett, CL,Stacey, D(2009).Decision aids for people facing health treatment or screening decisions (review).Cochrane Database Syst Rev,3,CD001431.
  24. Panjari, M,Bell, RJ,Davis, SR(2011).Sexual function after breast cancer.J Sex Med,8,294-302.
  25. Smith, AJ,Phipps, WR,Thomas, W,Schmitz, KH,Kurzer, MS(2013).The effects of aerobic exercise on estrogen metabolism in healthy premenopausal women.Cancer Epidemiol Biomarkers Prev,22(5),756-764.
  26. 王麗綺,張思平,郭旻奇,童承福,楊榮季(2014)。中醫藥輔助西醫癌症治療。藥學雜誌，30(1)，91-95。
  27. 吳俊義,郭純琦,游美珠,黃慧貞,許瑋怡,周東賢,王慈娟,陳秀珍,陳昀佑,林淑玫(2016).人體解剖學.台中市:華格納企業出版.
  28. 孫紅友,馬斌林,王若錚(2012)。放化療副反應的病因屬性及病機差異研究。新疆中醫藥，30(3)，15-17。
  29. 張金堅(2013)。美國乳癌2012 年會臨床新進展摘錄。當代醫學，472，98-103。
  30. 鄭紅剛,朴炳奎(2007)。淺談放化療毒副作用的中醫病因。中國中醫基礎醫學雜誌，13(10)，751-752。
  31. 賴鴻文,陳達人,陳守棟,張金堅(2015)。乳癌手術之進展－內視鏡乳癌微創手術及整型式乳房腫瘤切除手術。中華民國內膜異位症婦女協會會刊，22(7&8)，13-16。
print cancel